Target intelligence / Profile preview

RNA, U6 small nuclear 1117, pseudogene (RNU6-1117P)

Target
RNU6-1117P
Molecular classification
Other (processed pseudogene; non-coding RNA pseudogene)
01

Overview

RNU6-1117P is a processed **pseudogene** corresponding to the U6 small nuclear RNA gene, specifically the “RNA, U6 small nuclear 1117, pseudogene”[1][6]. Pseudogenes are **genomic DNA sequences similar to normal genes but typically nonfunctional**; they do not encode proteins or functional RNAs due to disabling mutations or truncated sequences[4][7]. U6 snRNA is a highly conserved small nuclear RNA that participates in pre-mRNA splicing as a core component of the spliceosome[5]. However, RNU6-1117P, as a pseudogene, **does not produce functional U6 RNA** and has no demonstrated role in splicing or any other biological process[1][4][6]. Pseudogenes like RNU6-1117P can result from retrotransposition of U6 snRNA transcripts, but are generally regarded as functionless genomic elements, though they may occasionally serve as evolutionary or genomic markers[4]. There is no evidence this locus is a therapeutic target, has drug interactions, or is involved in disease[1][4][6]. **Note:** - This entry is not a functional target; it is a pseudogene. - There is no evidence of functional protein, RNA product, or therapeutic relevance. - It should not be confused with U6 snRNA itself, which is essential for mRNA splicing[5].

Other names
RNU6-1117PU6 snRNA pseudogene 1117RNA, U6 snRNA pseudogene 1117
02

Mechanism of action

None

03

Biological functions

None (no known biological function; pseudogene)
04

Disease associations

None (not implicated in disease as a functional biomolecule)

Beyond the preview

Go deeper on RNA, U6 small nuclear 1117, pseudogene (RNU6-1117P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1117, pseudogene (RNU6-1117P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call